Memorial Sloan Kettering Cancer Center
2019 ASH Review on Venetoclax in the R/R CLL: With Additional Follow Up, Is This Regimen Holding up to the Promise of a Time Limited Therapy With Durable Remissions?
By
Cleveland Clinic's 20th Annual ASH Review
FEATURING
Anthony R. Mato
By
Cleveland Clinic's 20th Annual ASH Review
FEATURING
Anthony R. Mato
Login to view comments.
Click here to Login